Tech Transfer in Cell & Gene Therapy
Update: 2025-05-02
Description
In this episode, I'm joined by Brian Newsom, CEO of Carrigent. We discuss the challenges in effective tech transfer in the Cell and Gene Therapy industry. This includes effective documentation in CGT, why nuanced detail capture in SOPs is mission critical during tech transfer, and the different risk profiles of effective documentation between personalized medicine and generic drug production.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
